- Global Pharma News & Resources

Aptamers Market is Expected to Grow at an Ambitious CAGR of 21% between 2023 to 2032 | insightSLICE

The global Aptamers market size was estimated to be US$ 1.79 billion in 2021 and is expected to grow at a CAGR of 21% between 2023 to 2032.

Aptamers are short sequences of peptides or oligonucleotides that bind to a specific protein, lipid, or nucleic acid molecule. Aptamers are largely used in the precipitation, suppression, and characterization of DNA/proteins. Aptamers, in conjunction with tiny drugs, antibodies, and other aptamers, could be used as pharmacological leads, detecting instruments, and functional proteomics.

Aptamers can be bioengineered to focus on a wide range of targets with higher affinity and selectivity. Aptamers can also be used in diagnostics and treatments instead of antibodies because they are versatile, inexpensive, and act on similar binding principles.

Access the sample report: 

Global Aptamers Market Key Segments:

By Type:

  • Nucleic Acid
  • Peptide

By Application:

  • Diagnostics
  • Therapeutics
  • Research and Developments
  • Others

By Geography

  • North America
    • United States
    • Canada
    • Rest of North America
  • Europe
    • Germany
    • United Kingdom
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • India
    • China
    • Australia
    • Rest of Asia Pacific
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • South Africa
    • Rest of the Middle East & Africa
  • South America
    • Brazil
    • Rest of South America

Increased popularity of Aptamers owing to their benefits

Aptamers have attracted a lot of attention for prospective therapeutic and diagnostic uses, and they are now more popular than antibodies due to their key benefits, which include lower cost, the ability to not kill nearby cells, higher binding attachment, extended shelf life, and specificity.

The biotechnology sector’s expanding capacities for intensive research and development have also contributed to the expansion of the global aptamers market. Aptamers have also become increasingly important for pharmaceutical research and medicinal interventions, and this improved recombinant process of production has created a lucrative potential for market expansion.

The key players of the Global Aptamers Market are:

Among some of the largest companies in the global aptamers market include Aptus Biotech S.L., Aptamer Group, Aptamer Sciences Inc., Base Pair Biotechnologies Inc., TriLink BioTechnologies LLC, IBA GmbH, Kaneka Eurogentec S.A. (Kaneka Corporation), NeoVentures Biotechnology Inc., Vivonics Inc., Aptagen LLC, NOXXON Pharma, SomaLogic Inc., and Aptamer Sciencesase (PR).

Read more about the report inclusions:

Factors leading to Aptamers Market expansion

The increased incidence of fatal diseases is one of the primary factors supporting the requirement for novel and powerful detection tests based on aptamer therapy. An increase in the number of severe and genetic illnesses and greater investment in the therapeutic sector are two factors contributing to the economy for aptamers.

During the projected period, this market will also experience expansion driven by a rise in drug development and research for the advancement of therapeutic applications based on aptamers as well as growing consumer awareness of the benefits of aptamers over monoclonal antibodies.

Expanding collaborations between research institutions and the pharmaceutical industry, in addition to increased venture capital investment for aptamer investigations, are anticipated to offer market participants a wide range of growth potential.

Additionally, the introduction of advanced modification techniques may improve the therapeutic characteristics of aptamers and boost their resistance which will also support the Global aptamers market expansion. On the contrary hand, a relatively low level of acceptance compared to monoclonal antibodies is anticipated to impede commercial expansion, and a lack of skilled and trained specialists could be a barrier.

The growth of the aptamers market can also be linked to a rise in research and development (R&D) costs for novel diagnostic instruments, drugs, and their drivers. Aside from that, aptamers are being used more and more frequently all over the world because of their chemical synthesis, which eliminates batch-to-batch variation and speeds up research.

In addition, a number of other sectors collaborate with research centers and academic institutions to introduce innovative goods and increase their market share. The demand for a range of unique medical treatments as well as in the food and beverage industry is anticipated to rise as a result of these new approaches and techniques.

Request for a customization:

Regional performance of Aptamers Market

North America dominated the worldwide aptamers market primarily due to higher R&D spending and technical advancements in this area. The United States today holds a dominant position in the North American market as a result of supportive federal initiatives and an expansion in research facilities.

Aptamers are said to have the second-largest market in the world in Europe. Factors include the rising incidence of chronic diseases, the increase in clinical technology approvals, and the rising demand for aptamer-based medications in Europe all actively assist the market’s growth.

The expansion of the aptamers market throughout the Asia-Pacific region is being driven by the coordinated efforts of the leading companies in developing nations to enter unexplored markets. Rising R & D spending in this region’s biotechnology and pharmaceutical industries would aid in the market growth for aptamers throughout the anticipated period.

South America, the Middle East, and Africa are predicted to increase steadily during the projected period. It is also projected that improvements in aptamer manufacture would encourage the expansion of aptamers in South America.

Related reports:

Global CAR-T Cell Therapy Market:

Global Cervical Implants Market:

Hindering factors for growth of Aptamers Market

Strict regulatory guidelines for using aptamers, ethical and social problems with the use of genetic products, and slow market penetration are anticipated to be a hindrance to the Global Aptamers market progression. The lack of trained and knowledgeable personnel could also restrain the aptamer market’s development.

Global expansion is also expected to be hampered due to low awareness and adoption in middle and low-income countries. Many aptamer-based products have failed to fulfill all the necessary safety and efficacy standards in clinical research. Such unfavorable properties may also damage the reputation and have a negative effect on the growth of the Aptamers market.

Proceed to purchase:

insightSLICE is a market intelligence and strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting to provide end-to-end solutions. For more details, please contact our research and consulting team at

Contact us:

Alex R

+1 707 736 6633

Linkedin | Twitter

Editor Details

Last Updated: 08-Nov-2022